跳至主要内容
临床试验/NCT03321994
NCT03321994Unknown不适用

A Single-center, Randomized, Active-controlled and Evaluator-blind Investigator-initiated Trial to Evaluate and Compare the Efficacy and Safety of CT-guided Needle Guidance Using Stereotaxic Unit, Navigation Versus Conventional Biopsy Technique for the Patients Scheduled to Undergo Percutaneous Pulmonary Nodule Biopsy

Hyung Jin Won0 个研究点目标入组 106 人开始时间: 2017年11月最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
106
主要终点
Needle guide accuracy(mm)

研究概览

简要总结

The purpose of this study was to compare the safety and efficacy of CT-guided needle guidance using stereotaxic unit, navigation versus conventional biopsy technique for the patients scheduled to undergo percutaneous pulmonary nodule biopsy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
19 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with localized lesions such as pulmonary nodules on chest x-ray, CT or PET CT
  • Histopathologic examination is necessary if lung lesion is unknown
  • Histologic findings affect the disease stage or treatment plan
  • If the investigator decides to perform a percutaneous lung biopsy because the biopsy or diagnosis through the bronchoscopy is not possible or has low risk-benefit
  • Patient who have consented to contraception during the period of clinical trial participation (one month after the procedure)
  • Patient who voluntarily agree to participate in this clinical trial and are willing to comply with the protocol

排除标准

  • Patient with pulmonary function insufficiency
  • Patient who has difficulty in self-breathing (e.g, breathing through oxygen breathing apparatus)
  • Patient with Uncontrolled coagulation disorders (INR > 1.3 or Blood platelet count < 50,000/µl)
  • Patient with allergy to CT contrast agent
  • Patient under 19 years old or over 80 years old
  • Pregnant or lactating
  • Patient with uncontrollable systemic disease (e.g, uncontrolled hypertension, uncontrolled cardiovascular disease, etc.)
  • Patient who currently participating or has participated in other clinical trials within 30 days of the screening date
  • If it is judged inappropriate to participate in this clinical trial under the judgment of the investigator

研究组 & 干预措施

Conventional biopsy technique

Active Comparator

干预措施: conventional biopsy technique (Device)

Stereotaxic unit, navigation

Experimental

干预措施: stereotaxic unit, navigation (Device)

结局指标

主要结局

Needle guide accuracy(mm)

时间窗: 1 day

3D distance between target point and actual needle tip

次要结局

  • Needle guide angle deviation(°)(1 day)
  • Number of needle readjustments(1 day)
  • Number of needle reinsertion(1 day)
  • Needle insertion time(min)(1 day)
  • Procedure time(min)(1 day)

研究者

发起方
Hyung Jin Won
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hyung Jin Won

Professor

Asan Medical Center

相似试验